High level of microorganisms should not be present in non-sterile products for human use as they may cause adverse incidents. As an expert specializing in drug formulation, CD Formulation announces to ...
Avista Pharma Solutions has announced at the annual Interphex global conference in New York City that the $4 million expansion of its 26,000-square foot contract testing facility in Agawam, ...
Impact of Quality by Design on Topical Product Excipient Suppliers, Part II: Reasonable Expectations
This article will clarify reasonable expectations for the responsibilities of topical product formulation developers and for excipient suppliers regarding the information and samples for experiments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results